Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan and Spironolactone for Residual Renal Function in Peritoneal Dialysis
NCT02190318Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of losartan and spironolactone in chronic kidney disease (CKD), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
losartanspironolactone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02190318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190318.